Klingman & Associates, LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1662449
New York, NY
Position in REGN
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$239,439
-$62,663 QoQ
Shares Held
384
-1.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#998
of 1,322 holders
Holding Since
Sep 2023
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Klingman & Associates, LLC holds $511,150 across 2 Biotechnology names. REGN ranks #2 (46.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
547 | $271,711 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
384 | $239,439 |
All Filings in REGN
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $239,439 | 384 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $302,102 | 391 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $294,854 | 382 | Shares | Sole | 2026-01-29 | |
| 2025-06-30 | $200,550 | 382 | Shares | Sole | 2025-07-30 | |
| 2024-12-31 | $207,288 | 291 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $270,168 | 257 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $265,910 | 253 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $241,584 | 251 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $216,937 | 247 | Shares | Sole | 2024-01-29 | |
| 2023-09-30 | $200,802 | 244 | Shares | Sole | 2023-10-30 | |
| No filing history on record for this holder in this stock. | ||||||